H17.12 Insurance Policy Changes

ICD-10 H17.12 is officially defined as "Central corneal opacity, left eye." code H17.12 is referenced in 5 tracked payer policy changes from Aetna and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code H17.12 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Aug 19, 2026Medium impact
Corneal Graft and Amniotic Membrane Transplantation, Corneal Stromal Lenticule Transplantation, Limbal Stem Cell Transplantation, or Sural Nerve Grafting for Ocular Indications (CPB 0293, reviewed 2026-06-08)
Aetna considers preserved human amniotic membrane or limbal stem cell transplantation medically necessary for ocular surface reconstruction in members with limbal deficiency that is refractory to conventional treatment, when the member has a listed condition such as chemical or thermal injury of the ocular surface, Stevens-Johnson syndrome, bacterial keratitis, bullous keratopathy, or pterygium. More than 3 applications per eye of any human amniotic membrane graft for ophthalmic indications is considered not medically necessary, and an additional three applications per eye per year in each subsequent year may be medically necessary for chronic or recurrent ophthalmic conditions. Allogeneic corneal epithelial stem cell transplantation is listed as experimental, investigational, or unproven, and amniotic membrane placement for recurrent corneal erosions in epithelial basement membrane dystrophy is considered not medically necessary.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA11.072, Application and Removal of Tattoos
Independence Blue Cross reissued MA11.072 on 03/04/2026 to reaffirm its continuing position on tattoo application and removal coverage for Medicare Advantage members. The policy covers therapeutic tattoos (corneal leukoma concealment, radiation therapy marking, nipple/areola reconstruction), traumatic tattoo removal, and removal of tattoos with medical complications, while excluding cosmetic tattoos. No substantive coverage changes were made; this is a routine policy reissuance.
Independence Blue Cross · Identified Jun 19, 2026Low impact
MA11.072, Application and Removal of Tattoos
Independence Blue Cross reissued MA11.072 on 03/04/2026 to communicate the Company's continuing position on tattoo application and removal. No substantive changes to coverage criteria were made; this is a routine reissue. The policy clarifies that therapeutic tattoos (corneal leukoma concealment, radiation therapy marking, nipple/areola reconstruction) and medically necessary removal (traumatic tattoos, complications) are covered, while cosmetic tattooing is not covered under Medicare Advantage.
Independence Blue Cross · Identified Jun 19, 2026Low impact
11.08.05g, Application and Removal of Tattoos
This is a reissue of Independence Blue Cross policy 11.08.05g on tattoo application and removal with no substantive changes to coverage criteria. The policy continues to cover medically necessary therapeutic tattoos (corneal leukoma concealment, radiation therapy marking, breast reconstruction), traumatic tattoo removal, and removal due to medical complications, while excluding cosmetic tattoos. Billing teams should verify this reissue does not affect current claim processing, as coverage determinations remain unchanged from prior versions.
Independence Blue Cross · Identified Jun 19, 2026Low impact
11.08.05g, Application and Removal of Tattoos
Independence Blue Cross has reissued Policy 11.08.05g confirming its continuing position on tattoo application and removal. No substantive coverage changes were made; the policy maintains coverage for medically necessary therapeutic tattoos (corneal leukoma concealment, radiation therapy marking, breast reconstruction), traumatic tattoo removal, and removal due to medical complications, while excluding cosmetic tattoos. This is a routine reissue for policy maintenance purposes.

Watch H17.12

Get one email when a payer policy names H17.12, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code H17.12?

There are 5 tracked policy changes affecting code H17.12, including updates from Aetna, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code H17.12?

Payers that have issued tracked updates for code H17.12 include: Aetna, Independence Blue Cross.

How do I get notified when code H17.12 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code H17.12. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code H17.12?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Corneal Graft and Amniotic Membrane Transplantation, Corneal Stromal Lenticule Transplantation, Limbal Stem Cell Transplantation, or Sural Nerve Grafting for Ocular Indications (CPB 0293, reviewed 2026-06-08)

MA11.072, Application and Removal of Tattoos